MYELOKATHEXIS

Clinical trials for MYELOKATHEXIS explained in plain language.

Never miss a new study

Get alerted when new MYELOKATHEXIS trials appear

Sign up with your email to follow new studies for MYELOKATHEXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Experimental drug aims to fix faulty immune system in rare disorder

Disease control Recruiting now

This study is testing whether Mozobil, a drug already used for other conditions, can safely improve low white blood cell counts in adults with WHIMS syndrome. WHIMS is a rare genetic disorder where the immune system doesn't work properly, leading to frequent infections, warts, an…

Matched conditions: MYELOKATHEXIS

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

MYELOKATHEXIS

Get alerted when new MYELOKATHEXIS trials appear

Experimental drug aims to fix faulty immune system in rare disorder